| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amylyx Pharmaceuticals, Inc. (AMLX) has 7 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. AMLX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.32M | $51.99M | - | |
| CEO | 3.32M | $51.99M | - | |
| Dir | 812.9K | $12.74M | - | |
| CFO | 177.1K | $2.78M | - | |
| Other | 175.8K | $2.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | Mazzariello Gina53 | Chief Legal Officer | Sell | 2,838 | $18.76 | $53,230.66 | -5.8% | -89.9% | -81.3% | |
| Jan 9, 2024 | Klee Justin B.60 | Co-chief Executive Officer | Sell | 5,841 | $16.33 | $95,372.43 | -0.2% | -83.6% | -77.0% | |
| Jan 9, 2024 | Frates James M83 | Chief Financial Officer | Sell | 2,716 | $16.33 | $44,347.12 | -2.4% | -83.6% | -77.0% | |
| Jan 9, 2024 | Cohen Joshua B60 | Co-chief Executive Officer | Sell | 5,841 | $16.33 | $95,372.43 | -0.2% | -83.6% | -77.0% | |
| Jan 9, 2024 | Yeramian Patrick D84 | Chief Medical Officer | Sell | 2,812 | $16.33 | $45,914.62 | -1.3% | -83.6% | -77.0% | |
| Dec 15, 2023 | Firestone Karen | Director | Buy | 4,000 | $14.97 | $59,880.00 | +400.0% | -77.7% | -71.0% | |
| Aug 15, 2023 | Mazzariello Gina53 | Chief Legal Officer | Sell | 6,164 | $20.88 | $128,686.44 | -11.2% | -38.4% | -89.9% | |
| May 16, 2023 | Frates James M83 | Chief Financial Officer | Sale+OE | 32,500 | $26.94 | $875,451.20 | -22.5% | -22.8% | -93.3% | |
| May 15, 2023 | Yeramian Patrick D84 | Chief Medical Officer | Sale+OE | 11,965 | $29.03 | $347,358.31 | -5.4% | -25.4% | -93.4% | |
| Apr 17, 2023 | Yeramian Patrick D84 | Chief Medical Officer | Sale+OE | 49,579 | $30.54 | $1,513,942.35 | -10.6% | -26.2% | -93.5% |